Premium
POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL.
Author(s) -
Luminari S.,
Marcheselli L.,
Manni M.,
Anastasia A.,
Vitolo U.,
Chiarenza A.,
Rigacci L.,
Angelucci E.,
Fama A.,
Pulsoni A.,
Rattotti S.,
Angrilli F.,
Gaidano G.,
Stelitano C.,
Bertoldero G.,
Cascavilla N.,
Salvi F.,
Ferreri A.J.,
Tarantino V.,
Bellei M.,
Federico M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_91
Subject(s) - follicular lymphoma , medicine , clinical endpoint , surrogate endpoint , stage (stratigraphy) , follicular phase , oncology , lymphoma , randomized controlled trial , biology , paleontology